detect
enterovirus
exclud
crossdetect
rhinovirus
challeng
sequenc
similar
commonli
use
conserv
target
molecular
assay
addit
simultan
detect
differenti
enterovirus
parechovirus
would
benefici
similar
clinic
pictur
present
virus
sensit
specif
realtim
rtpcr
protocol
address
clinic
need
would
valuabl
molecular
diagnost
laboratori
report
multiplex
nucleic
acid
base
assay
use
hydrolysi
probe
target
nontransl
region
detect
differenti
enterovirus
parechovirus
without
crossdetect
rhinovirus
assay
shown
detect
enterovirus
belong
differ
speci
varieti
specimen
type
without
detect
differ
speci
rhinovirus
laboratori
valid
show
assay
sensit
specif
reproduc
easi
set
use
gener
cycl
condit
assay
implement
diagnost
test
patient
sampl
high
throughput
fashion
famili
picornavirida
belong
order
picornaviral
current
consist
speci
group
genera
includ
parechoviru
enteroviru
genu
parechoviru
divid
two
speci
human
parechoviru
hpev
ljungan
viru
speci
hpev
current
consist
type
formerli
classifi
enteroviru
genu
echoviru
respect
anoth
isol
origin
classifi
base
serolog
crossreact
reclassifi
genu
enteroviru
consist
speci
enteroviru
enteroviru
b
enteroviru
c
enteroviru
rhinoviru
rhinoviru
b
rhinoviru
c
caus
human
diseas
three
polioviru
pv
serotyp
belong
speci
enteroviru
c
www
piconaviridaecom
studi
enteroviru
ev
refer
exclus
human
enterovirus
consist
speci
b
c
rhinovirus
refer
rv
major
human
enteroviru
ev
infect
asymptomat
howev
caus
wide
spectrum
acut
diseas
includ
mild
upper
respiratori
ill
hand
foot
mouth
diseas
herpangina
pleurodynia
asept
mening
enceph
acut
flaccid
paralysi
neonat
sepsislik
diseas
addit
acut
ill
ev
also
associ
sever
chronic
diseas
differ
ev
type
associ
certain
clinic
manifest
coxsackieviru
enteroviru
strong
associ
outbreak
hand
foot
mouth
diseas
hemorrhag
conjunct
sever
outbreak
involv
case
fatal
enceph
infant
children
asiapacif
region
human
rhinovirus
rv
respons
mani
case
common
cold
also
frequent
found
otiti
media
sinus
bronchiti
pneumonia
asthma
exacerb
sever
rv
type
circul
continu
differenti
rv
ev
infect
often
clinic
import
specif
identif
virus
implic
support
manag
patient
becom
signific
specif
antivir
drug
becom
avail
highlight
cdc
health
advisori
recent
outbreak
sampl
test
posit
commonli
use
assay
unabl
distinguish
ev
rv
test
confirm
http
realtim
rtpcr
target
nontransl
region
ntr
use
sensit
specif
detect
ev
rv
howev
sequenc
similar
region
creat
difficulti
differenti
human
parechoviru
infect
describ
mostli
infant
young
children
howev
histor
underdiagnos
difficulti
detect
tradit
method
viru
isol
infect
often
appear
asymptomat
associ
mild
gastrointestin
respiratori
symptom
although
sever
neonat
diseas
includ
sepsi
mening
enceph
hepat
describ
sever
diseas
outcom
link
infect
hpev
type
epidemiolog
natur
histori
preval
hpev
gener
fulli
establish
similar
clinic
pictur
caus
ev
hpev
multiplex
detect
two
virus
benefici
speedi
costeffect
diagnosi
also
specif
detect
ev
without
crossreact
rv
aid
diagnosi
guid
support
treatment
turnaroundtim
diagnosi
ev
hpev
infect
improv
use
molecular
test
benefici
hospit
children
report
develop
valid
multiplex
realtim
rtpcr
assay
multiplex
rtrtpcr
target
ntr
simultan
detect
ev
hpev
use
hydrolysi
probe
format
easili
implement
high
throughput
test
patient
sampl
diagnost
set
repres
sequenc
ntr
differ
ev
rv
serotyp
use
design
primer
ntrfor
ntrrev
probe
ntrprobe
detect
ev
avoid
cross
reactiv
rv
align
includ
repres
sequenc
serotyp
classic
ev
name
poliovirus
echovirus
coxsacki
virus
coxsacki
b
virus
number
enterovirus
also
includ
sequenc
rv
classifi
within
repres
sequenc
serotyp
rhinoviru
b
ntr
hpev
avail
genbank
use
design
primer
ntrfor
ntrrev
probe
ntrvic
detect
probe
detect
ev
hpev
design
minor
groov
bind
probe
purchas
appli
biosystem
abi
foster
citi
california
label
ned
vic
report
dye
respect
panevclonefor
thoma
bries
person
commun
design
amplif
longer
region
ntr
ev
includ
detect
region
gener
plasmid
clone
prepar
invitro
rna
similarli
ntrclonfor
ntrclonrev
use
amplif
hpev
detect
region
gener
plasmid
sequenc
sourc
oligonucleotid
use
studi
provid
tabl
onestep
rtpcr
method
use
amplif
detect
ev
hpev
simultan
taqman
fast
viru
onestep
rtpcr
master
mix
abi
use
mm
sens
antisens
primer
mm
probe
five
microlitr
extract
rna
combin
ml
master
mix
revers
transcript
step
perform
c
min
follow
incub
c
amplif
includ
cycl
denatur
c
follow
anneal
extens
data
acquisit
c
fast
realtim
pcr
system
abi
panevclonefor
use
amplif
longer
region
ntr
gener
plasmid
clone
detect
region
region
amplifi
repres
differ
speci
similarli
ntrclonfor
ntrclonrev
use
amplif
detect
region
pcr
product
clone
use
topo
ta
clone
dual
promot
kit
life
technolog
california
usa
plasmid
dna
linear
use
restrict
enzym
hind
iii
transcrib
use
express
promega
madison
wi
usa
synthes
negativestrand
rna
invitro
transcrib
rna
spectrophotometr
quantifi
calcul
copi
number
tenfold
serial
dilut
quantifi
invitro
transcrib
rna
ev
repres
differ
speci
hpev
use
determin
assay
sensit
use
assay
singleplex
multiplex
format
end
point
sensit
assess
test
dilut
triplic
three
independ
run
use
multiplex
assay
ev
hpev
detect
specif
singleplex
multiplex
assay
determin
test
high
copi
number
anonym
sampl
contain
addit
rv
character
sequenc
belong
speci
n
b
n
c
n
anonym
patient
sampl
test
use
design
assay
thoroughli
verifi
whether
crossreact
primer
probe
reproduc
multiplex
assay
evalu
use
cultur
spike
background
matrix
anonym
oral
swab
sampl
cross
threshold
ct
high
low
viral
load
repres
ev
differ
speci
includ
speci
speci
b
vaccin
strain
speci
c
speci
test
multiplex
assay
human
pev
test
assay
includ
ev
type
base
partial
sequenc
gene
assess
competit
inhibit
target
detect
case
coinfect
ev
hpev
spike
sampl
test
differ
concentr
virus
cultur
spike
give
ct
valu
rang
spike
give
ct
valu
rang
univers
transport
media
utm
extract
use
use
easymag
autom
extractor
biom
erieux
durham
nc
usa
extract
test
singl
multiplex
assay
specimen
previous
test
posit
ev
nucleic
acid
sequenc
base
amplif
nasba
assay
isotherm
transcriptionbas
amplif
method
use
valid
multiplex
assay
includ
posit
blood
csf
fece
amniot
fluid
ct
valu
rang
neg
csf
sampl
viral
rna
differ
specimen
matric
extract
use
easymag
accord
manufactur
instruct
result
indic
tabl
includ
number
replic
test
posit
endpoint
averag
ct
valu
end
point
cv
ct
valu
limit
detect
multiplex
assay
estim
around
copi
invitro
transcrib
rna
ml
templat
hpev
limit
detect
rang
copi
invitro
rna
vaccin
strain
multiplex
assay
sensit
use
singleplex
assay
larg
compar
around
copi
invitro
transcrib
rna
ml
templat
limit
detect
singleplex
assay
copi
invitro
rna
vaccin
strain
less
copi
hpev
linear
amplif
target
obtain
log
templat
concentr
use
invitro
rna
differ
speci
effici
amplif
rang
singleplex
multiplex
assay
amplifi
viral
bacteri
respiratori
pathogen
potenti
caus
coinfect
ev
hpev
thu
establish
specif
total
rv
character
sequenc
speci
n
b
n
c
n
test
neg
singleplex
multiplex
assay
show
cross
detect
rv
ev
primer
probe
rhinovirus
continu
test
assay
becom
avail
laboratori
ensur
specif
detect
ev
eight
sampl
ct
valu
rang
test
triplic
three
independ
run
result
nine
replic
valu
intraassay
variabl
cv
calcul
use
replic
within
run
eight
sampl
test
vari
interassay
variabl
calcul
use
valu
obtain
differ
run
rang
show
reproduc
detect
good
precis
differ
viral
load
differ
specimen
type
ct
valu
interassay
intraassay
variabl
shown
tabl
sensit
nasba
methodolog
compar
realtim
rtpcr
molecularbas
diagnost
procedur
rna
virus
addit
specimen
test
ev
detect
nasba
assay
readili
avail
laboratori
thu
use
valid
retrospect
posit
neg
patient
sampl
use
accuraci
panel
assay
valid
provid
concord
result
nasba
multiplex
realtim
rtpcr
assay
includ
posit
blood
csf
fece
amniot
fluid
ct
valu
rang
neg
csf
sampl
high
low
viral
load
repres
virus
enteroviru
b
c
list
method
detect
multiplex
assay
expect
ct
valu
quantifi
invitro
rna
use
determin
endpoint
sensit
templat
copi
number
ml
extract
use
per
reaction
indic
averag
standard
deviat
sd
coeffici
variat
cv
indic
variabl
cross
threshold
valu
endpoint
result
coinfect
studi
indic
tabl
ct
valu
obtain
specimen
coinfect
compar
specimen
singl
target
infect
show
competit
inhibit
detect
either
target
differ
viral
load
test
enterovirus
common
import
human
pathogen
although
major
infect
asymptomat
ev
caus
sever
sever
ill
molecular
method
especi
realtim
rtpcr
becom
diagnost
modal
choic
given
rapid
turn
around
time
high
sensit
provid
methodolog
previous
report
ntr
commonli
chosen
target
high
degre
conserv
among
differ
ev
type
origin
high
conserv
stem
secondari
structur
requir
intern
ribosom
entri
site
ire
function
ntr
unfortun
high
conserv
also
extend
high
homolog
ntr
rv
mani
rtpcr
assay
ev
cross
detect
least
rv
studi
design
valid
set
primer
probe
crossdetect
rv
detect
classic
ev
well
numer
newli
describ
ev
high
sensit
lack
cross
detect
particularli
use
specif
laboratori
diagnosi
respiratori
sampl
sinc
rhinovirus
enterovirus
commonli
infect
respiratori
tract
infect
respiratori
tract
rhinovirus
preval
enterovirus
ensur
detect
rhinovirus
algorithm
use
laboratori
includ
initi
test
respiratori
viral
panel
rvp
assay
luminex
molecular
diagnost
austin
tx
usa
assay
detect
enterovirus
rhinovirus
howev
distinguish
assay
describ
manuscript
use
differenti
clinic
pictur
warrant
enterovirusspecif
assay
assay
describ
manuscript
also
use
specif
detect
enterovirus
parechovirus
sampl
blood
csf
front
line
assay
consequ
strong
constraint
mutat
ntr
expect
assay
also
detect
new
emerg
ev
caution
must
howev
exercis
regard
alreadi
sever
isol
newli
design
shown
constitut
new
clade
within
speci
c
display
import
differ
sequenc
ntr
sever
rtpcr
assay
target
ntr
fail
detect
base
sequenc
comparison
primer
probe
sequenc
isol
would
predict
assay
would
also
fail
detect
virus
exact
geograph
distribut
clinic
frequenc
virus
new
clade
remain
establish
given
difficulti
design
comprehens
assay
detect
ev
cross
react
rv
would
argu
best
way
improv
current
assay
order
detect
new
clade
would
add
primer
probe
specif
clade
multiplex
mix
work
requir
toward
goal
human
parechovirus
constitut
new
speci
within
picornaviru
genu
rel
laboratori
routin
test
group
thu
full
natur
histori
virus
still
remain
understood
genom
sequenc
data
avail
hpev
region
target
report
primer
probe
base
insilico
analysi
virus
detect
equal
effici
parechovirus
belong
differ
genu
ntr
region
quit
distinct
ev
rv
thu
quit
feasibl
design
primer
probe
specif
hpev
multiplex
primer
probe
ev
report
mutiplex
assay
sensit
detect
differ
speci
ev
hpev
test
abl
exclud
detect
rv
assay
show
specif
excel
reproduc
make
suitabl
implement
diagnost
set
varieti
specimen
type
includ
blood
csf
fece
swab
amniot
fluid
use
viral
detect
even
though
antivir
drug
effect
ev
hpev
infect
current
avail
test
aid
patient
manag
provid
diagnosi
reduc
antibiot
use
sensit
nucleic
acid
base
detect
methodolog
would
contribut
better
understand
epidemiolog
natur
histori
agent
report
multiplex
realtim
rtpcr
assay
success
implement
diagnosi
ev
hpev
infect
routin
diagnost
laboratori
oral
sampl
test
triplic
three
independ
run
intraassay
variabl
calcul
run
interassay
variabl
calcul
base
three
run
averag
standard
deviat
sd
coeffici
variat
cv
indic
variabl
cross
threshold
valu
endpoint
winnipeg
canada
provid
aliquot
vaccin
strain
polioviru
would
also
like
thank
kara
gill
daniel
zarra
technologist
molecular
diagnost
depart
excel
technic
help
work
support
provinci
laboratori
public
health
alberta
